Authors

• Mylin Ann Torres (ORCID: https://orcid.org/0000-0003-3582-5216)
• Antonio C. Wolff (ORCID: https://orcid.org/0000-0003-3734-1063)
• Gelareh Sadigh (ORCID: https://orcid.org/0000-0003-3233-1878)
• Fenghai Duan (ORCID: https://orcid.org/0000-0002-5084-0070)
• Ruth C. Carlos (ORCID: https://orcid.org/0000-0001-7055-7662)
• Ilana Graetz (ORCID: https://orcid.org/0000-0003-3664-5815)
• JoRean D. Sicks
• Scott D. Ramsey
• Judy Hancock
• Lynne I. Wagner (ORCID: https://orcid.org/0000-0001-9685-4796)
• Jane Meisel (ORCID: https://orcid.org/0000-0002-2642-865X)
• Ilana F. Gareen (ORCID: https://orcid.org/0000-0002-0457-5595)
• Maryanne Thangarajah

Institutions

• University of North Carolina at Chapel Hill (US)
• Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
• Emory University (US)
• Brown University (US)
• Fred Hutch Cancer Center (US)
• University of California, Irvine Medical Center (US)
• Cancer Research for the Ozarks (US)
• Sidney Kimmel Cancer Center (US)
• Sidney Kimmel Comprehensive Cancer Center (US)
• Columbia University (US)

Publication Details

Journal

Contemporary Clinical Trials

Published

2025-11-20

DOI

https://doi.org/10.1016/j.cct.2025.108145

Primary Topic

Advanced Breast Cancer Therapies

Type

article

Field-Weighted Citation Impact

0.00